Hi I was just doing a quick Google search to find up to date information on the developments surrounding Allergan's Oxymetazoline treatment for subtype 1 Rosacea and came across a 2015 Research and Development document issued by Allergen which appears to detail the adverse effects of the medication in clinical trialsScreen Shot 2016-05-17 at 21.58.10.jpgScreen Shot 2016-05-17 at 21.57.58.jpg (NO REBOUND EFFECT NOTED!!!)
See the attached pages from the document (pages 19 and 21).
I can't upload the full document but the direct URL is https://www.google.co.uk/url?sa=t&rc...22129774,d.ZGg
See the attached pages from the document (pages 19 and 21).
I can't upload the full document but the direct URL is https://www.google.co.uk/url?sa=t&rc...22129774,d.ZGg
Comment